ImmuCell Corporation (NASDAQ: ICCC)
$4.20
-0.0700 ( -1.64% ) 3.1K
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
Market Data
Open
$4.20
Previous close
$4.27
Volume
3.1K
Market cap
$32.73M
Day range
$4.21 - $4.24
52 week range
$4.05 - $5.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Mar 06, 2024 |
8-k | 8K-related | 16 | Feb 27, 2024 |
8-k | 8K-related | 16 | Feb 27, 2024 |
8-k | 8K-related | 14 | Jan 08, 2024 |
8-k | 8K-related | 13 | Nov 16, 2023 |
8-k | 8K-related | 13 | Nov 13, 2023 |
10-q | Quarterly Reports | 90 | Nov 13, 2023 |
8-k | 8K-related | 13 | Oct 05, 2023 |
4 | Insider transactions | 1 | Sep 06, 2023 |
4 | Insider transactions | 1 | Aug 30, 2023 |